RJA
GSK icon

Ross\Johnson & Associates’s GSK GSK Stock Holding History

Ross\Johnson & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26K Hold
24
– – 0.02% 84
2026
Q1 		$1.32K Hold
24
– – 0.02% 78
2025
Q4 		$1.18K Hold
24
– – 0.02% 87
2025
Q3 		$1.04K Hold
24
– – 0.02% 80
2025
Q2 		$922 Hold
24
– – 0.02% 80
2025
Q1 		$930 Hold
24
– – 0.02% 213
2024
Q4 		$812 Buy
+24
New +$864 0.02% 84

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ross\Johnson & Associates's GSK Position: Q2 2026 in Review

Ross\Johnson & Associates held its GSK (GSK) position steady in Q2 2026 at 24 shares worth $1.26K. The position accounts for 0.02% of the portfolio, ranked #84.

Ross\Johnson & Associates first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.32K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Ross\Johnson & Associates held 24 shares of GSK worth $1.26K as of Q2 2026.
  • Ross\Johnson & Associates left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.02% of Ross\Johnson & Associates's portfolio in Q2 2026, its #84 holding.
  • Ross\Johnson & Associates first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Ross\Johnson & Associates's GSK position peaked at $1.32K in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.